Tag: commercialisation
AusBiotech applauds launch of Medical Science Co-Investment Plan to boost biotech sector
AusBiotech has welcomed the launch of the Medical Science Co-Investment Plan, which pinpoints four primary investment areas in the medical science domain: medical devices, complex therapeutics, digital health, and sustainability.
SiBox testing completed, 1414 Degrees moves toward commercialisation
1414 Degrees announced its relocation to the Tonsley Innovation District following the completion of the demonstration phase of its SiBox thermal energy storage project, marking a significant step towards commercialisation.
First Graphene spearheads breakthrough in green hydrogen catalyst
First Graphene Limited announced progress in the commercialisation of graphene materials with the development of new electrocatalysts tailored for the burgeoning 'green hydrogen' sector.
ClearVue secures funds to fast-track Gen-2 product testing, certification
ClearVue Technologies, a pioneer in smart building materials, has secured $4 million through a Placement, accompanied by the launch of a $2 million Share Purchase Plan (SPP).
Australian gov’t invests $50 million to advance artificial heart development
The Australian Government has allocated $50 million towards the development and commercialisation of what it claims to be the world's most advanced artificial heart.
PARKD strikes deal with BlueScope subsidiary for metal deck support system
PARKD Ltd, an Australian modular relocatable carpark manufacturer, has officially sealed a significant deal with Fielders Steel Roofing, a division of BlueScope Steel Limited.
Altech unveils ‘excellent’ progress in 60 kWh CERENERGY prototypes
Altech Batteries has characterised its advancements as "excellent," as it undergoes the manufacturing of two ABS60 60 kWh CERENERGY battery prototypes in Germany intended for customer performance testing.
Grant applications open for non-profits in $392.4M Industry Growth Program
Not-for-profit industry organisations can now apply for grants to provide expert, sector-specific guidance to participating startups and scaleups as part of the Australian Government’s $392.4 million Industry Growth Program.
AFT Pharmaceuticals spearheads progress in women’s health with Hyloris partnership
AFT Pharmaceuticals announced its partnership with Hyloris Pharmaceuticals, based in Belgium, to develop a novel treatment, HY-091, for Vulvar Lichen Sclerosus (VLS), addressing the critical need for effective solutions in an area where approved treatments are limited.
IperionX CEO maps out visionary path for 2024 targeting titanium advancements
In a letter addressed to shareholders and stakeholders, Anastasios Arima, the CEO of ASX-listed IperionX Limited, has expressed optimism and confidence as the company looks ahead to a year of significant growth, innovation, and success.
Featured Article
Australian manufacturing in 2025: Challenges and pathways to progress
The Australian manufacturing sector, long considered the backbone of the nation’s economy, is standing at a crossroads in 2025.
